Home | Welcome to Contract Pharma   
Last Updated Thursday, July 31 2014
Print

Agere Expands Manufacturing Capabilities



Published November 6, 2012
Agere Pharmaceuticals has added cGMP manufacturing capabilities to support clients entering Phase IIb trials. The new capacity extends services for formulation development to oral bioavailability of BCS II and IV compounds.  
 
“We’ve extended our cGMP spray drying capabilities in response to our clients’ requests to continue with Agere as they enter Phase IIb clinical trials,” said Marshall Crew, Agere’s president and chief executive officer. “This is a natural progression for us, as expanding services delivers efficiencies to our clients.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On